Characterization of the tumor micro-environment after administration of glucocorticoids to understand their radiosensitization effect by Crokart et al.
Characterization of the tumor micro-environment after administration of glucocorticoids to understand their 
radiosensitization effect 
 
N. Crokart1, B. F. Jordan1, C. Baudelet1, G. O. Cron1, J. Hotton1, K. Radermacher1, V. Gregoire2, N. Beghein1, P. Martinive3, O. Feron3, B. Gallez1 
1Biomedical magnetic resonance unit, Université Catholique de Louvain, Brussels, B, Belgium, 2Laboratory of Molecular Imaging and Experimental Radiotherapy, 
Université Catholique de Louvain, Brussels, B, Belgium, 3Laboratory of Pharmacology and Therapeutics, Université Catholique de Louvain, Brussels, B, Belgium 
Introduction:  
We hypothesized that glucocorticoids may enhance tumor radiosensitivity by increasing tumor oxygenation (pO2) via inhibition of mitochondrial respiration as we 
previously described such effect with nonsteroidal anti-inflammatory drugs (1). This phenomenon is in accordance with the literature and is a direct effect of 
glucocorticoids on cytochrome c-oxidase  (2-3). 
Materials and Methods: 
Two types of tumors were used in this study: FSaII and TLT tumors implanted in the gastrocnemius muscle of mice. Glucocorticoids were administered by IP injection. 
Hydrocortisone at a dose of 7.7 mg/kg, Dexamethasone at a dose of 5 mg/kg and Prednisolone at a dose of 75 mg/kg. 
Oxygen pressure (measured by EPR oximetry with a 1.2 GHz spectrometer) and blood flow (monitored with DCE MRI at 4.7 Tesla) were monitored in the tumor before 
and after treatment.Oxygen consumption by tumor cells was measured ex-vivo using X-Band EPR spectroscopy. To assessed the potential benefit of the oxygen effect, 
tumors were irradiated to 25 Gy using an RX irradiator . The effect of hydrocortisone on FSaII cells was evaluated by a clonogenic cell survival assay. 
Results: 
All glucocorticoids tested induced an increase in tumor pO2. Fig 1 shows the increase in tumor pO2 after hydrocortisone administration in two tumor  models. DCE MRI 
studies carried out after hydrocortisone indicated that the increase in tumor oxygenation is not due to an increase in tumor perfusion. At the time of maximal 
reoxygenation, we found that the percentage of perfused tumor area (region were the contrast agent could flow characterized by significant values for Ktrans and/or vp)  
was decreased (Fig 2). These results are in accordance with other perfusion measurements performed with the patent blue technique. The treatment by hydrococrtisone 
induced a significant decrease in oxygen consumption by tumor cells (Fig 3). Finally, we observed a longer regrowth delay when irradiation was performed 30 min after 
injection of hydrocortisone compared with radiation alone (table). This effect is not due to a direct radiosensitization effect of hydrocortisone on the cell as evaluated by 
survival clonogenic assay (Fig 4). 
Discussion 
Our results show that glucocorticoids induce an increase in tumor oxygenation. Since this increase was not related to an increase in blood supply, it is likely that an 
effect on oxygen consumption is involved. At the time of increase in pO2, there was an increase in the regrowth delay after irradiation, suggesting that the 
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Figure 1: pO2 (mmHg) (Mean +/-
SEM)  measured by EPR oximetry
before and after hydrocortisone (HC)
treatment. n=5/group 
A : TLT tumors  
B : FSaII tumors  
Figure 2: Perfusion of control 
versus HC treated FSaII group. 
A : Percentage of perfused voxels 
measured by DCE-MRI 
 (n=6/group) Statistic analysis : 























8.46 ± 0.53 *** 12.46 ± 0.51 hydrocortisone + 25 Gy 
4.84 ± 0.95 *** 8.66 ± 0.88 saline + 25 Gy 
  4.00 ± 0.13 hydrocortisone 
  3.83 ± 0.45 saline 
Regrowth delay  
(days) 
Time to 12 mm  
(days) 
Groups 
Table : Regrowth delay of 4 groups of FSaII tumor groups.   
Saline (n=7), HC (n=7), saline + 25 Gy (n=6) and HC + 25 Gy (n=5)  
Statistical analysis : One way Anova Tukey’s Multiple Comparison test  

















Fig 4 : Effect of hydrocortisone (HC) on FSaII tumor cells evaluated by
clonogenic cell survival assay. 2 Gy irradiation induced a decrease in the
number of colonies (p<0.05, 2 way anova) which was not enhanced by
hydrocortisone. n=4/group. 









Figure 3: Oxygen consumption 
measured ex-vivo by X-band 
EPR. n=4/group 
⁯ = control ■ = hydrocortisone 
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